标题
KCa3.1-a microglial target ready for drug repurposing?
作者
关键词
-
出版物
GLIA
Volume 64, Issue 10, Pages 1733-1741
出版商
Wiley
发表日期
2016-04-28
DOI
10.1002/glia.22992
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds
- (2016) Roberto Würth et al. DRUG DISCOVERY TODAY
- The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke
- (2016) Yi-Je Chen et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Drug Repurposing for the Development of Novel Analgesics
- (2016) Marco Sisignano et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Ion Channels in Innate and Adaptive Immunity
- (2015) Stefan Feske et al. Annual Review of Immunology
- Immunotherapy in acute myeloid leukemia
- (2015) Dolores A. Grosso et al. CANCER
- Metabotropic glutamate receptors as drug targets: what's new?
- (2015) Ferdinando Nicoletti et al. CURRENT OPINION IN PHARMACOLOGY
- Drug repositioning and repurposing: terminology and definitions in literature
- (2015) Joris Langedijk et al. DRUG DISCOVERY TODAY
- Central nervous system myeloid cells as drug targets: current status and translational challenges
- (2015) Knut Biber et al. NATURE REVIEWS DRUG DISCOVERY
- IKCa Channels Are a Critical Determinant of the Slow AHP in CA1 Pyramidal Neurons
- (2015) Brian King et al. Cell Reports
- KCa3.1/IK1 Channel Regulation by cGMP-Dependent Protein Kinase (PKG) via Reactive Oxygen Species and CaMKII in Microglia: An Immune Modulating Feedback System?
- (2015) Roger Ferreira et al. Frontiers in Immunology
- Targeting of microglial KCa3.1 channels by TRAM-34 exacerbates hippocampal neurodegeneration and does not affect ictogenesis and epileptogenesis in chronic temporal lobe epilepsy models
- (2014) Tanja Ongerth et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Microglial K+channel expression in young adult and aged mice
- (2014) Tom Schilling et al. GLIA
- Blunted IgE-Mediated Activation of Mast Cells in Mice Lacking the Ca2+-Activated K+ Channel KCa3.1
- (2014) E. Shumilina et al. JOURNAL OF IMMUNOLOGY
- Neuronal expression of the intermediate conductance calcium-activated potassium channel KCa3.1 in the mammalian central nervous system
- (2014) Ray W. Turner et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- IL-4 type 1 receptor signaling up-regulates KCNN4 expression, and increases the KCa3.1 current and its contribution to migration of alternative-activated microglia
- (2014) Roger Ferreira et al. Frontiers in Cellular Neuroscience
- KCa3.1 Modulates Neuroblast Migration Along the Rostral Migratory Stream (RMS) In Vivo
- (2013) Kathryn L. Turner et al. CEREBRAL CORTEX
- Target validation using chemical probes
- (2013) Mark E Bunnage et al. Nature Chemical Biology
- Glial cell changes in epilepsy: Overview of the clinical problem and therapeutic opportunities
- (2013) Jacqueline A. Hubbard et al. NEUROCHEMISTRY INTERNATIONAL
- TRAM-34, a Putatively Selective Blocker of Intermediate-Conductance, Calcium-Activated Potassium Channels, Inhibits Cytochrome P450 Activity
- (2013) Jay J. Agarwal et al. PLoS One
- Selective Activation of KCa3.1 and CRAC Channels by P2Y2 Receptors Promotes Ca2+ Signaling, Store Refilling and Migration of Rat Microglial Cells
- (2013) Roger Ferreira et al. PLoS One
- Cancer drug discovery by repurposing: teaching new tricks to old dogs
- (2013) Subash C. Gupta et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo
- (2013) G D'Alessandro et al. Cell Death & Disease
- Drug repositioning for Alzheimer's disease
- (2012) Anne Corbett et al. NATURE REVIEWS DRUG DISCOVERY
- Genetic KCa3.1-Deficiency Produces Locomotor Hyperactivity and Alterations in Cerebral Monoamine Levels
- (2012) Kate Lykke Lambertsen et al. PLoS One
- Intermediate conductance calcium-activated potassium channels modulate summation of parallel fiber input in cerebellar Purkinje cells
- (2012) J. D. T. Engbers et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Drug repositioning for orphan diseases
- (2011) D. Sardana et al. BRIEFINGS IN BIOINFORMATICS
- Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the gardos channel blocker senicapo
- (2011) Kenneth I. Ataga et al. BRITISH JOURNAL OF HAEMATOLOGY
- Ion Channels on Microglia: Therapeutic Targets for Neuroprotection
- (2011) Stephen D. Skaper CNS & Neurological Disorders-Drug Targets
- The lymphocyte potassium channels Kv1.3 and KCa3.1 as targets for immunosuppression
- (2011) Jenny Lam et al. DRUG DEVELOPMENT RESEARCH
- The KCa3.1 Blocker TRAM-34 Reduces Infarction and Neurological Deficit in a Rat Model of Ischemia/Reperfusion Stroke
- (2011) Yi-Je Chen et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Inhibition of the Ca2+-Dependent K+ Channel, KCNN4/KCa3.1, Improves Tissue Protection and Locomotor Recovery after Spinal Cord Injury
- (2011) D. Bouhy et al. JOURNAL OF NEUROSCIENCE
- Control of hypothalamic-pituitary-adrenal stress axis activity by the intermediate conductance calcium-activated potassium channel, SK4
- (2011) Zhi Liang et al. JOURNAL OF PHYSIOLOGY-LONDON
- Physiology of Microglia
- (2011) Helmut Kettenmann et al. PHYSIOLOGICAL REVIEWS
- What Happened to Anti-CD33 Therapy for Acute Myeloid Leukemia?
- (2011) Joseph G. Jurcic Current Hematologic Malignancy Reports
- Amyloid-β Protein Oligomer at Low Nanomolar Concentrations Activates Microglia and Induces Microglial Neurotoxicity
- (2010) Izumi Maezawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ion channels in monocytes and microglia / brain macrophages: Promising therapeutic targets for neurological diseases
- (2010) Claudia Eder JOURNAL OF NEUROIMMUNOLOGY
- The art of the chemical probe
- (2010) Stephen V Frye Nature Chemical Biology
- Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis
- (2010) L. Di et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic potential of KCa3.1 blockers: recent advances and promising trends
- (2010) Heike Wulff et al. Expert Review of Clinical Pharmacology
- Senicapoc (ICA-17043): a potential therapy for the prevention and treatment of hemolysis-associated complications in sickle cell anemia
- (2009) Kenneth I Ataga et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Non-selective cation channel activity is required for lysophosphatidylcholine-induced monocyte migration
- (2009) Tom Schilling et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator
- (2009) Gregory J. del Zoppo et al. STROKE
- Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia
- (2008) K. I. Ataga et al. BLOOD
- Novel Inhibitors of the Gardos Channel for the Treatment of Sickle Cell Disease
- (2008) Grant A. McNaughton-Smith et al. JOURNAL OF MEDICINAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started